5:07 PM ET
10-Q
Financial Results
Maia Biotechnology Q3 2026 Results: Net Loss of $7.18M, Loss Narrows
For the nine months ended September 30, 2026, MAIA Biotechnology reported a net loss of $21.5 million, driven by $23.3 million in operating expenses. The company significantly strengthened its cash position to $21.3 million, up from $8.7 million at year-end 2025, primarily through a public offering that raised approximately $31.0 million.
- Key figure
- Net loss $7.18M